Citations

Mayo Clinic

Clear

88160 citation(s) found for "NA".

Inpatient Outcomes and Complications After Left Atrial Appendage Occlusion in Rural Versus Urban Hospitals in the United States
Nguyen, Amanda, Khan, Muhammad Zia, Neely, Joseph, Alruwaili, Waleed, Naveed, Muhammad Abdullah , Devera, Justin Lim, Leon, William E., Agarwal, Siddharth, Asad, Zain Ul Abideen, Khan, Samrina, Gonuguntla, Karthik , Ice, Daniel, M, el-Musa Munir, Munir, Muhammad Bilal , Munir, Muhammad Bilal , Nguyen, Amanda , Khan, Muhammad Zia , Neely, Joseph, Alruwaili, Waleed , Naveed, Muhammad Abdullah, Devera, Justin , Agarwal, Siddharth , Asad, Zain Ul Abideen , Ice, Daniel

Clinical Cardiology | June 27, 2026 | Volume: 49 | Issue: 7 | Pages: No page available

10.1002/clc.70397 | PMID 42363838 Get It

ABSTRACT Background Disparities in management of atrial fibrillation in rural and urban hospitals across the U.S. have been reported. However, studies investigating disparities regarding outcomes and complications after left atrial appendage occlusion (LAAO) based on hospital location are lacking. Objective To evaluate differences in outcomes and complications related to LAAO among rural and urban hospitals. Methods The National Inpatient Sample was used to identify patients who underwent LAAO implantations in the U.S. from 2016−2020. Study endpoints assessed included inpatient complications, outcomes, and resource utilization after LAAO procedures among rural and urban hospitals. Results From 2016−2020, there were a total of 87 315 and 1985 LAAO device placements in urban and rural hospitals, respectively. Baseline characteristics were similar among both groups, with a few exceptions. After multivariable adjustment for confounders, odds of inpatient complications and mortality were similar among both groups. However, rural LAAO recipients experienced greater rates of discharge to an acute care facility (3.3% vs 2.4%, p = 0.01), as well as lower costs (aOR: 0.58, 95% CI: 0.49–0.69) and length of stay (aOR: 0.89, 95% CI: 0.81–0.98). Conclusions A majority of LAAO implantations occurred in urban hospitals in the U.S. Baseline characteristics and adjusted odds of inpatient complications and mortality were similar in rural and urban recipients. However, important differences were described regarding resource utilization and disposition. Further investigation into the specific factors driving these inequities is encouraged to promote improved access to and outcomes of cardiovascular care for rural residents.
Weight Changes in Children and Adolescents with Epilepsy and Overweight/Obesity Treated with Zonisamide
Salama, Mostafa , Touma, Elsie, Hassan, Doha , Wong-Kisiel, Lily, Keating, Gesina, Kumar, S, Salama, Mostafa , Keating, Gesina F.

Childhood Obesity | June 27, 2026 | Volume: 22 | Issue: 7 | Pages: 457-465

10.1177/21532176261461791 | PMID 42363812 Get It

Objective: To examine changes in weight status after initiating zonisamide in children with epilepsy and elevated body mass index (BMI). Study Design: Retrospective chart review of children aged 2 to ≤18 years with epilepsy treated with zonisamide, assessing BMI changes over 2 years. Results: A total of 140 children were included; mean age (SD) at initiation was 9.60 years (3.93). BMI categories included 28 children with severe obesity, 28 with mild–moderate obesity, 28 with overweight, and 56 with healthy weight. Participants were 56.6% female, 91.4% non-Hispanic/Latino, and 88.6% White. At 2 years, BMI z score decreased significantly across all BMI groups: severe obesity −0.38 ( N = 13, 95% CI −0.64 to −0.13; p = 0.003), mild-moderate obesity −0.39 ( N = 15, 95% CI −0.62 to −0.16; p = 0.001), overweight −0.60 ( N = 14, 95% CI −0.84 to −0.36; p < 0.001), and healthy weight −0.46 ( N = 21, 95% CI −0.63 to −0.28; p < 0.001). Significant BMI z score reductions were also observed across age groups: 2–10 years −0.48 ( N = 40, 95% CI −0.62 to −0.34), >10–13 years −0.27 ( N = 15, 95% CI −0.50 to −0.04), and ≥13 years −0.63 ( N = 12, 95% CI 0.89 to −0.36). Conclusions: BMI reduction persisted up to 2 years following zonisamide initiation in children with epilepsy. Further prospective studies are needed to evaluate the weight loss effect and safety of zonisamide in children with epilepsy and elevated BMI.
Ultrafast oscillations in the human brain and their functional significance
Curot, Jonathan , Pail, Martin , Służewska‐Niedźwiedź, Monika , Curot, Jonathan , Stacey, William , Worrell, Gregory A , Brázdil, Milan , Trávníček, Vojtěch , Román, Róbert , Plešinger, Filip , Barbeau, Emmanuel J. , Kucewicz, Michał T. , Klimeš, Petr , Cimbálník, Jan , Jurák, Pavel , Stacey, William C. , Worrell, Gregory A.

Epilepsia | June 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/epi.70324 | PMID 42363785 Get It

Abstract Objective The upper frequency limit of human brain activity remains unknown. Using ultrahigh sampling rate (≥20 kHz) intracranial microelectroencephalography, this study aimed to systematically explore and quantitatively characterize brain field oscillations beyond the established high‐frequency oscillation range (>2 kHz), and to determine their relationship to epileptogenic tissue. Methods We analyzed intracranial electroencephalographic recordings from 15 patients with drug‐resistant epilepsy, comprising 466 microcontacts and 434 macrocontacts implanted in mesiotemporal structures across four international epilepsy centers. A custom spectrogram‐based detector optimized for ultrahigh frequencies was developed to identify ultrafast oscillations (UFOs; >2 kHz). UFO rates were assessed in epileptic (successfully resected) and nonepileptic hippocampi and compared with established electrophysiological biomarkers, including interictal epileptiform discharges, ripples, and fast ripples. Statistical comparisons were performed using mixed‐effects models to account for intersubject and interelectrode variability. Results We identified a previously undescribed class of short‐duration oscillatory events spanning 2–8 kHz. UFOs occurred at significantly higher rates in epileptic compared with nonepileptic mesiotemporal regions, with the strongest differentiation observed in the 2–3‐kHz band. Two distinct UFO phenotypes were consistently observed: (1) spindlelike, narrow‐band oscillations and (2) sharp‐onset, rapidly decaying bursts. Both forms were prevalent within epileptic hippocampi but were exceedingly rare in nonepileptic structures. UFOs exhibited pronounced temporal intermittency and spatial focality and frequently arose independently of ripples, fast ripples, and very high‐frequency oscillations, indicating that they represent a distinct electrophysiological phenomenon. Macrocontacts detected UFOs only exceptionally, highlighting the necessity of microelectrode recordings to capture activity in this ultrahigh‐frequency regime. Significance These findings substantially extend the known frequency range of human brain field activity and identify ultrafast oscillations as a novel biomarker of neuronal hyperexcitability. UFOs likely reflect pathological microcircuit dynamics inaccessible to conventional clinical recordings and provide new insights into the organization and pathophysiology of epileptogenic networks.
The Iron Lung: Ferroptosis and Iron Regulation in Aging and Lung Diseases
Ngassie, Maunick Lefin Koloko , Ortiz, Yamillie , Ravi, Preetham , Pfeffer-Kleemann, Daniel A., Borkar, Niyati A. , Pabelick, Christina M. , Prakash, Y. S. , Koloko Ngassie, Maunick Lefin , Pfeffer-Kleemann, Daniel , Borkar, Niyati , Pabelick, Christina M , Prakash, Y S

Physiology | June 27, 2026 | Volume: 42 | Issue: 1 | Pages: 000-000

10.1152/physiol.00062.2025 | PMID 42363743 Get It

Iron is an important metal element regulating biological processes such as gene expression, electron transport, cell proliferation, differentiation and division, and cellular respiration. Regulation of iron levels is therefore critical, with excess iron accumulation leading to iron-dependent lipid peroxidation and cell death (ferroptosis). Factors such as aging and environmental exposures (e.g., high/low oxygen, particulate iron) can disrupt iron homeostasis. Iron-dependent processes influence downstream pathways such as inflammation, mitochondrial energetics, and remodeling (proliferation, fibrosis), pathways involved in lung diseases particularly at the extremes of age, from hyperoxic lung injury in neonates to chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis (PF) that increase with age. Although these diseases involve structural and functional changes in bronchial versus alveolar compartments, including airway hyperreactivity, altered mucus production, cell proliferation and migration, increased extracellular matrix (ECM) remodeling, senescence, and metabolic dysregulation, the casual or consequential links between iron dysregulation and disease pathology, particularly with aging, are still being investigated. The aim of this topical review is to 1) highlight current knowledge regarding iron regulation in normal lung versus lung diseases, 2) identify known roles of iron in lung homeostasis and the contribution of iron dysregulation in lung diseases with aging, and 3) explore the potential benefit of targeting iron regulation and/or ferroptosis in lung diseases.
NMDAR ‐antibody encephalitis: Seizure semiology and EEG findings
Andraus, Maria Emília Cosenza , Liem, Bernard , Aurangzeb, Sidra , Symmonds, Mkael , Handel, Adam E. , Irani, Sarosh R. , Andraus, Maria Emilia C , Sen, Arjune , Irani, Sarosh R , Handel, Adam

Epileptic Disorders | June 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/epd2.70327 | PMID 42363715 Get It

Abstract Background N‐methyl‐D‐aspartate receptor antibody encephalitis (NMDAR‐Ab‐E) is an autoantibody‐mediated disorder, characterized by acute development of neuropsychiatric symptoms, seizures, movement disorders, and autonomic instability. Objectives To describe acute seizure semiology and electroencephalogram (EEG) findings in patients with a first episode of NMDAR‐Ab‐E. Methods Medical records and EEG results were retrospectively evaluated from 14 adult patients with definite NMDAR‐Ab‐E, recruited between April 2009 and September 2017, and followed up until October 2024. Results A total of 92.8% (13/14) were women with a mean age of 29.6 years. 85.7% (12/14) patients experienced seizures. Focal and/or generalized seizures were described at presentation or in the first days of the illness in 57% (8/14). EEGs showed diffuse slowing in 13/14 and this coexisted with epileptiform activity in 10/13; fast frequencies in 7/13 (potentially owing to a benzodiazepine effect); and asymmetric focal slowing in 6/13. Six patients had periods of rhythmic slow activity (focal or diffuse), without evolution to electrographic seizures. An extreme delta brush (EDB) pattern was recorded in 2/13 patients, and this was associated with non‐convulsive status epilepticus in one of these individuals. Significance Most patients in this case series of NMDAR‐Ab‐E were young adult females with early focal and/or generalized seizures. Diffuse slowing in theta/delta range was the most common EEG finding, with or without epileptiform discharges, focal slowing, superimposed fast activities, and focal or diffuse rhythmic slowing. An EDB pattern was rare. Even with non‐specific findings, EEG seems to be a sensitive tool to aid diagnosis and decision‐making in NMDAR‐Ab‐E.
Decoding the complexity of tricuspid regurgitation prognostic drivers using explainable artificial intelligence
Tsaban, Gal , Benfari, Giovanni , Essayagh, Benjamin A, Lee, Eunjung, Hernandez, Manuel A Montoya, Thapa, Prabin , Nkomo, Vuyisile T. , Pislaru, Sorin V. , Michelena, H, Enriquez-Sarano, M, Montoya Hernandez, Manuel A, Sabbah, Michael S. , Nkomo, Vuyisile T , Benfari, Giovanni , Essayagh, Benjamin , Hernandez, Manuel Alejandro Montoya , Michelena, Héctor I. , Enriquez‐Sarano, Maurice

European Heart Journal - Cardiovascular Imaging | June 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/ehjci/jeag168 | PMID 42363702 Get It

Abstract Aims Prognosis in tricuspid regurgitation (TR) is shaped by complex clinical and haemodynamic interactions, complicating risk stratification. We aimed to use explainable artificial intelligence (EAI) to model these relationships and identify key predictors of outcomes. Methods and results We analysed long-term all-cause mortality in a large prospective registry of patients with native TR across the full severity spectrum. Patients underwent detailed clinical evaluation and quantitative Doppler-echocardiography. Supervised EAI models were applied to identify and rank predictors of mortality under medical therapy, capturing non-linear associations and interactions among baseline characteristics. Among 9761 patients [mean age 73 ± 15 years; 56.9% women; effective regurgitant orifice area (EROA) 40 (30–56) mm2; regurgitant volume 39 (29–53) mL/beat; 42% severe TR], 2676 deaths occurred during 3.8 ± 4.6 years of follow-up. EAI identified and ranked 20 prognostic determinants of survival. Haemodynamic measures, led by elevated pulmonary-artery systolic and right-atrial pressures, were strongest, followed by age and comorbidity. TR-related variables ranked next, led by right ventricular dysfunction and EROA, which outperformed integrative TR grade and TRIScore. Left-ventricular parameters were less influential. Non-linear effects, including those involving ejection fraction, and interactions such as higher EROA-related risk with elevated pulmonary pressures or lower TRIScore (both P &lt; 0.03) were observed. Proportional hazards models confirmed EROA as the strongest TR severity marker (P &lt; 0.0001), with excess mortality beginning at 40 mm2 and increasing further at 60 mm2. Conclusion EAI ranked mortality predictors in TR, highlighting patient factors, haemodynamics, TR-specific measures, and left-ventricular function. Among TR-specific measures, EROA and TRIScore were most prognostic. Recognizing their impact can refine risk stratification, guide intervention timing, and inform long-term management.
MYH11 ‐Related Hereditary Type 2 Visceral Myopathy in a Large Kindred: Diagnostic Odyssey With Milder Clinical Manifestations
Muniswamy, Jai Kumar Rajavoor , Zele, Elise Van, Agely, Ali , Muthusamy, Karthik , Van Zele, Elise, Muthusamy, Karthik , Rajavoor Muniswamy, Jai Kumar

American Journal of Medical Genetics Part A | June 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ajmg.a.70235 | PMID 42362996 Get It

ABSTRACT MYH11 ‐related hereditary type 2 visceral myopathy is a rare smooth muscle disorder typically presenting in infancy with severe gastrointestinal and genitourinary dysfunction. We describe a 73‐year‐old female with lifelong symptoms of gastrointestinal and urinary dysfunction, including chronic constipation, neurogenic bladder, recurrent urinary tract infections, gastroparesis, and pelvic organ prolapse. A multigenerational family history revealed similar visceral smooth muscle abnormalities among 14 affected individuals over five generations, suggesting autosomal dominant inheritance. Whole‐genome sequencing identified a heterozygous, likely pathogenic variant in MYH11 c.5819del; p.(Pro1940HisfsTer91), consistent with the diagnosis of autosomal dominant type 2 visceral myopathy. This variant causes production of an abnormally elongated myosin‐heavy chain, disrupting muscle contractile function. This individual's survival into her eighth decade reflects long‐term clinical stability, possibly attributable to the variant's milder effect. We describe the clinical course of the disease, along with a comprehensive review of previously described individuals with the same variant. This case broadens the phenotypic spectrum of MYH11 ‐associated visceral myopathy, demonstrating that late‐onset, milder forms can occur and remain compatible with long‐term survival with optimal supportive management. Comprehensive genetic evaluation identifies primary disorders, enabling precise diagnosis, tailored management, and informed genetic counseling for complex phenotypes.
Aging-Related lncRNA Expression in Bipolar Disorder: Effects of Familial Liability and Childhood Trauma
Ekinci, Sultan , Yeşiloğlu, Buket , Fettahoğlu, İbrahim , ÜNLÜ, Canay PAMUKÇU , Celik, Hidayet Ece Arat, Şenol, Şevin Hun , Balaç, Sinem, Kaymakçı, Esma Çörekli, Kendirlioglu, Burcu Kok, Frye, Mark A. , Altıntaş, Merih , Çelik, Hidayet Ece Arat, Kaymakçı, Esma Çörekli , Kendirlioglu, Burcu Kok , Özerdem, Ayşegül , Ceylan, Deniz

No container title available | June 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.15.26355706 Get It

Abstract Introduction Bipolar disorder (BD) has been associated with increased medical burden and accelerated biological aging. Long non-coding RNAs (lncRNAs) regulate molecular pathways related to cellular senescence, inflammation, and telomere maintenance, which are implicated in both BD and aging. This study examined whether aging-related lncRNA expression reflects familial vulnerability or illness-specific effects, and whether childhood trauma and lifestyle factors modulate these signatures within a gene–environment framework. Methods In this cross-sectional study, expression levels of aging-related lncRNAs, including Antisense Non-coding RNA in the INK4 Locus (ANRIL), HOX Transcript Antisense Intergenic RNA (HOTAIR), Nuclear Enriched Abundant Transcript 1 (NEAT1), Taurine Upregulated Gene 1 (TUG1), Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1), Growth Arrest-Specific 5 (GAS5), and Telomerase RNA Component (TERC), were measured in peripheral blood mononuclear cells (PBMCs) from individuals with bipolar disorder (BD) (n=68), siblings without BD diagnosis (SIB) (n=54), and healthy controls (HC) (n=70) using quantitative reverse transcription polymerase chain reaction (RT-qPCR). Childhood trauma and lifestyle were assessed using the Childhood Trauma Questionnaire (CTQ) and the Healthy Lifestyle Profile II (HPLP-II). Principal component analysis generated a composite aging-related lncRNA factor. Results At the individual transcript level, NEAT1 and TERC were elevated, whereas GAS5 was reduced, in both BD and SIB relative to HC. The aging-related lncRNA composite score was higher in BD and SIB than in HC (F = 7.315, p = 0.001). Familial liability to BD (presence vs. absence of familial liability ) showed a significant main effect on the composite score (F(1,182)=8.18, p=0.005) and interacted with childhood trauma (F(1,182)=10.14, p=0.002). In multivariable models, total CTQ and physical neglect were independently associated with lower composite scores, while familial liability remained a positive predictor (all p<0.001). Conclusions Aging-related lncRNA alterations mark familial vulnerability to BD and are shaped by childhood trauma within a gene–environment interaction framework.
With Great Cost Comes Great Responsibility: Who Will Own the Rising Costs of Bladder Cancer Care?
Sharma, Vidit , Boorjian, Stephen A., Joyce, Daniel D , Joyce, Daniel , Boorjian, Stephen A.

Journal of Urology | June 26, 2026 | Volume: 216 | Issue: 4 | Pages: 487-489

10.1097/ju.0000000000005185 | PMID 42361214 Get It

Clinical and Molecular Effects of TYK2/JAK1 Inhibition in Dermatomyositis
Mangold, Aaron, Vleugels, Ruth Ann , Shahriari, Neda , Castillo, Rochelle , Gehlhausen, Jeffrey, Jiang, Rundong , Haemel, Anna Kaye, Fox, Jennifer Callahan, Bogle, Rachael , Roberts, Bryce T. , Penner, Scott , Li, Xing, Ramirez, Zeni , Tsoi, Alex, Shaw, Katharina, Cascino, Matthew, Johnson, BE, Kahlenberg, J. Michelle, Gudjonsson, Johann E., Paik, Julie J. , Sluzevich, Jason C. , Haemel, Anna K. , Bogle, R, Shaw, Katharina S. , Cascino, Matthew D., Kahlenberg, J. Michelle , Christopher‐Stine, Lisa , Fernandez, Anthony P , Fiorentino, David Franklin , Werth, Victoria P. , Gudjonsson, Johann E

No container title available | June 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.15.26354270 Get It

Abstract Dermatomyositis is driven by overactivation of type I and II interferons and other proinflammatory cytokines that signal via the JAK-STAT pathway. We conducted a 12-week, open-label study of brepocitinib, an oral TYK2/JAK1 inhibitor, in five adults with severe cutaneous dermatomyositis. Treatment was associated with rapid, clinically meaningful improvement in cutaneous disease activity. Single-cell and spatial transcriptomic profiling of lesional skin showed marked suppression of interferon-responsive pathways and inflammatory cell states by week 4. Together with findings from a Phase 3 randomized trial in DM patients with skin and muscle involvement (VALOR, NCT05437263 ), these data support TYK2/JAK1 inhibition as a promising therapeutic strategy for DM.